logo
Worker shortage from ICE raids threatens the US food supply chain

Worker shortage from ICE raids threatens the US food supply chain

Canada News.Net5 days ago
SACRAMENTO, California: California's multibillion-dollar farms are facing a growing crisis—not from drought or pests, but from a sudden disappearance of labor. Immigration raids earlier this month have driven away a large share of the workforce, leaving crops unharvested and farmers deeply anxious.
Lisa Tate, a sixth-generation farmer in Ventura County, has seen the fallout firsthand. Her county is a hub for fruit and vegetable production, much of it hand-picked by undocumented immigrants.
"In the fields, I would say 70 percent of the workers are gone," Tate told Reuters. "If 70 percent of your workforce doesn't show up, 70 percent of your crop doesn't get picked and can go bad in one day. Most Americans don't want to do this work. Most farmers here are barely breaking even. I fear this has created a tipping point where many will go bust."
Ventura County and the Central Valley—major agricultural zones north of Los Angeles—have been hit hard. Two farmers, two field supervisors, and four immigrant workers described how the ICE operations, part of President Donald Trump's immigration crackdown, have emptied the fields at peak harvest time.
One Mexican farm supervisor said he normally oversees 300 workers to prep strawberry fields. On a recent day, only 80 showed up, and another supervisor reported a drop from 80 workers to just 17.
According to the California Department of Food and Agriculture, the state produces over a third of America's vegetables and more than three-quarters of its fruits and nuts. In 2023, its farms generated nearly US$60 billion in sales.
But many of those crops are now at risk. "If things are ripe, such as our neighbors' bell peppers here, [and] they don't harvest within two or three days, the crop is sunburned or over-mature," said Greg Tesch, who farms in central California. "We need the labor."
The chilling effect has been swift. Of the four immigrant workers Reuters spoke with, two said they are undocumented and fearful. One 54-year-old, who's worked U.S. fields for 30 years, said many of his colleagues have stopped showing up.
"If they show up to work, they don't know if they will ever see their family again," he said. Another added, "We wake up scared. We worry about the sun, the heat, and now a much bigger problem — many not returning home."
Community groups said that while some workers are staying home initially, many return out of economic necessity. Others are taking precautions like carpooling with legal residents or sending U.S. citizen family members to run errands.
Experts warn the raids could ripple far beyond the fields. Douglas Holtz-Eakin, a former director of the Congressional Budget Office, estimates that around 80 percent of U.S. farmworkers are foreign-born, nearly half undocumented. "This is bad for supply chains, bad for the agricultural industry," he said. Price hikes may follow.
Bernard Yaros, lead U.S. economist at Oxford Economics, noted that native-born workers are unlikely to replace the missing labor. "Unauthorized immigrants tend to work in different occupations than those who are native-born," he said.
Even authorized workers feel unsafe. "Nobody feels safe when they hear the word ICE, even the documented people," said Tesch. "We know that the neighborhood is full of a combination of those with and without documents."
President Trump acknowledged the disruption in a post on Truth Social, saying ICE raids were "taking very good, long-time workers away" from farms and hotels. "They're not citizens, but they've turned out to be great," he later told reporters, adding that a policy response was being considered—though no changes have yet been announced.
White House spokeswoman Anna Kelly said Trump "has always stood up for farmers" and would continue to boost agriculture while enforcing immigration laws. For California's farmers, though, time—and labor—may be running out.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

El Salvador recalls its ambassador from Mexico and disputes origin of drug flight
El Salvador recalls its ambassador from Mexico and disputes origin of drug flight

Toronto Star

timean hour ago

  • Toronto Star

El Salvador recalls its ambassador from Mexico and disputes origin of drug flight

SAN SALVADOR, El Salvador (AP) — El Salvador President Nayib Bukele recalled his ambassador to Mexico and demanded the country clarify its security chief's comments that an intercepted plane carrying cocaine had originated in El Salvador. Bukele labeled the information from Mexico Security Secretary Omar García Harfuch as 'FALSE' in a post on X, that went on to detail the plane's alleged flight path. Bukele also pointed out that the three men arrested with the plane were Mexican citizens.

Canadian pharmaceutical industry alarmed after Trump threatens 200% tariff on drug imports
Canadian pharmaceutical industry alarmed after Trump threatens 200% tariff on drug imports

Vancouver Sun

timean hour ago

  • Vancouver Sun

Canadian pharmaceutical industry alarmed after Trump threatens 200% tariff on drug imports

WASHINGTON — Canada likely isn't the main target of U.S. President Donald Trump's threat to impose a 200 per cent tariff on pharmaceutical imports, an industry representative said Wednesday — but his plan could still put parts of the Canadian sector in peril. 'Canada is not the target but we could get caught in the crossfire if there are broad-based tariffs on pharmaceuticals,' said Canadian Generic Pharmaceutical Association president Jim Keon. On Tuesday, Trump floated the idea of massive pharmaceutical tariffs but said he would give drug makers up to a year and a half before introducing the duties. Start your day with a roundup of B.C.-focused news and opinion. By signing up you consent to receive the above newsletter from Postmedia Network Inc. A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Sunrise will soon be in your inbox. Please try again Interested in more newsletters? Browse here. Trump launched an investigation under Section 232 of the Trade Expansion Act of 1962 into pharmaceuticals in April, claiming national security concerns linked to America's reliance on imported drugs. A lot of those imported drugs come from China and India. A report on that investigation has not been released but Commerce Secretary Howard Lutnick told CNBC Tuesday that details about pharmaceutical duties would come out at the end of the month. Generic medicines are used to fill about 90 per cent of all prescriptions in the United States. Canadian exports amount to less than five per cent of all generic medicines sold in the U.S., Keon said. Such a low volume shouldn't trigger any U.S. concerns about an overreliance on imports, Keon said. He said there is hope that the economic and security agreement being negotiated between Canada and the United States will ensure pharmaceuticals remain tariff-free. Ottawa and the Trump administration have set a July 21 target to finalize the deal. 'We have learned over the last six to eight months not to overreact to the statements and wait and see what actually comes out in the executive order in the tariffs themselves,' Keon said. But if Canada is not spared from the looming pharmaceutical duties, Keon said, that would have impacts for Canadian and foreign companies that manufacture drugs in this country. Generic pharmaceuticals have a low profit margin. Without access to the American market, Keon said, it might not be practical for some companies in Canada to continue producing certain generic medicines for the domestic market. Drugmakers have said that tariffs on pharmaceuticals could also cause shortages in the United States and increase costs for Americans who need medicine. 'I think as a Canadian industry and as part of a global industry, we've been operating without tariffs for the last several decades and imposing tariffs is going to increase costs and complicate supply chains,' Keon said. Keon said there is support for the Trump administration launching separate studies looking for ways to reduce prices and make the U.S. a more attractive market for drug manufacturing. Certain measures like harmonizing regulatory standards with those of other countries would help reduce unnecessary costs, he said. Our website is the place for the latest breaking news, exclusive scoops, longreads and provocative commentary. Please bookmark and sign up for our daily newsletter, Posted, here .

Canadian pharmaceutical industry alarmed after Trump threatens 200% tariff on drug imports
Canadian pharmaceutical industry alarmed after Trump threatens 200% tariff on drug imports

Edmonton Journal

timean hour ago

  • Edmonton Journal

Canadian pharmaceutical industry alarmed after Trump threatens 200% tariff on drug imports

Drugmakers say that tariffs on pharmaceuticals could cause shortages in the U.S. and increase costs for Americans who need medicine. Photo by WilliamWASHINGTON — Canada likely isn't the main target of U.S. President Donald Trump's threat to impose a 200 per cent tariff on pharmaceutical imports, an industry representative said Wednesday — but his plan could still put parts of the Canadian sector in peril. THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY Subscribe now to read the latest news in your city and across Canada. Exclusive articles by David Staples, Keith Gerein and others, Oilers news from Cult of Hockey, Ask EJ Anything features, the Noon News Roundup and Under the Dome newsletters. Unlimited online access to Edmonton Journal and 15 news sites with one account. Edmonton Journal ePaper, an electronic replica of the print edition to view on any device, share and comment on. Daily puzzles, including the New York Times Crossword. Support local journalism. SUBSCRIBE TO UNLOCK MORE ARTICLES Subscribe now to read the latest news in your city and across Canada. Exclusive articles by David Staples, Keith Gerein and others, Oilers news from Cult of Hockey, Ask EJ Anything features, the Noon News Roundup and Under the Dome newsletters. Unlimited online access to Edmonton Journal and 15 news sites with one account. Edmonton Journal ePaper, an electronic replica of the print edition to view on any device, share and comment on. Daily puzzles, including the New York Times Crossword. Support local journalism. REGISTER / SIGN IN TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account. Share your thoughts and join the conversation in the comments. Enjoy additional articles per month. Get email updates from your favourite authors. THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK. Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors 'Canada is not the target but we could get caught in the crossfire if there are broad-based tariffs on pharmaceuticals,' said Canadian Generic Pharmaceutical Association president Jim Keon. On Tuesday, Trump floated the idea of massive pharmaceutical tariffs but said he would give drug makers up to a year and a half before introducing the duties. Get the latest headlines, breaking news and columns. By signing up you consent to receive the above newsletter from Postmedia Network Inc. Please try again Trump launched an investigation under Section 232 of the Trade Expansion Act of 1962 into pharmaceuticals in April, claiming national security concerns linked to America's reliance on imported drugs. A lot of those imported drugs come from China and India. A report on that investigation has not been released but Commerce Secretary Howard Lutnick told CNBC Tuesday that details about pharmaceutical duties would come out at the end of the month. Generic medicines are used to fill about 90 per cent of all prescriptions in the United States. Canadian exports amount to less than five per cent of all generic medicines sold in the U.S., Keon said. Such a low volume shouldn't trigger any U.S. concerns about an overreliance on imports, Keon said. He said there is hope that the economic and security agreement being negotiated between Canada and the United States will ensure pharmaceuticals remain tariff-free. Ottawa and the Trump administration have set a July 21 target to finalize the deal. 'We have learned over the last six to eight months not to overreact to the statements and wait and see what actually comes out in the executive order in the tariffs themselves,' Keon said. But if Canada is not spared from the looming pharmaceutical duties, Keon said, that would have impacts for Canadian and foreign companies that manufacture drugs in this country. Generic pharmaceuticals have a low profit margin. Without access to the American market, Keon said, it might not be practical for some companies in Canada to continue producing certain generic medicines for the domestic market.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store